Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.
Acknowledgment of Support
This activity is supported by an educational grant from Bausch + Lomb.
Advances In™ Uveitic Macular Edema: The Future of Treatment for Patients With UME
Release Date: March 31, 2021
Expiration Date: March 31, 2022
Activity Overview
This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of uveitic macular edema, with a forward-looking perspective on how new and novel agents might impact clinical practice. The essentials of diagnosis, current and emerging treatment strategies, and management of treatment-related toxicities will be presented in a multimedia format, including a series of video interviews with an expert thought leader integrated into text-based elements.
Acknowledgement of Commercial Support
This activity is supported by an educational grant from Bausch + Lomb.
Instructions for This Activity and Receiving Credit
You may immediately download your certificate. |
Target Audience
This educational activity is directed toward ophthalmologists and other health care professionals involved in management of patients with uveitic macular edema.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Discuss the various etiologies of uveitic macular edema
- Evaluate clinical and imaging findings in a differential diagnosis of uveitic macular edema
- Describe the efficacy, safety, benefits, and limitations of existing and future corticosteroid treatments in patients with uveitic macular edema
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.
Faculty
Stanley Truhlsen Jr. Professor of Ophthalmology
Director, Uveitis and Vitreoretinal Disease
Truhlsen Eye Institute
University of Nebraska Medical Center
Omaha, Nebraska
Disclosures: Consultant: Bausch + Lomb.
Assistant Professor
Emory Eye Center
Division of Uveitis and Medical Retina
Atlanta, Georgia
Disclosures: Grant/Research Support: NEI K23.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
Login or Register to Start Activity
Please use the form below to Register or Log In to begin Activity.
.jpg "PER")
